MIRM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.06%

Insider Buying (Last 12 Months): $4,424,479.85

Insider Selling (Last 12 Months): $1,621,582.31

Mirum Pharmaceuticals Insider Trading History Chart

Mirum Pharmaceuticals Share Price & Price History

^$24.17

▲ +0.36 (1.51%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

Mirum Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/27/2024	Eric Bjerkholt	CFO	Buy	2,000	$24.80	$49,600.00	14,000
3/25/2024	Peter Radovich	COO	Sell	4,303	$25.80	$111,017.40	29,013
3/18/2024	Eric Bjerkholt	CFO	Buy	2,000	$25.80	$51,600.00	12,000
2/2/2024	Jolanda Howe	SVP	Sell	735	$26.19	$19,249.65	1,759
1/8/2024	Christopher Peetz	CEO	Sell	5,209	$28.03	$146,008.27	110,125
1/8/2024	Jolanda Howe	SVP	Sell	528	$28.04	$14,805.12	722
1/8/2024	Lara Longpre	Insider	Sell	1,019	$28.04	$28,572.76	105,254
1/8/2024	Peter Radovich	COO	Sell	1,408	$28.03	$39,466.24	36,485
12/5/2023	Jolanda Howe	SVP	Sell	2,500	$32.40	$81,000.00
9/14/2023	Michael G. Grey	Director	Sell	14,216	$32.00	$454,912.00
9/11/2023	Eric Bjerkholt	CFO	Buy	10,000	$29.65	$296,500.00	10,000
9/11/2023	Patrick J Heron	Director	Buy	4,687	$30.30	$142,016.10	152,678
8/31/2023	Patrick J Heron	Director	Buy	147,991	$26.25	$3,884,763.75	147,991
8/25/2023	Jolanda Howe	SVP	Sell	3,459	$26.23	$90,729.57
7/3/2023	Christopher Peetz	CEO	Sell	5,498	$25.65	$141,023.70	115,334
7/3/2023	Jolanda Howe	SVP	Sell	915	$25.65	$23,469.75	3,459
7/3/2023	Lara Longpre	Insider	Sell	1,004	$25.65	$25,752.60	105,839
7/3/2023	Peter Radovich	COO	Sell	1,425	$25.65	$36,551.25	37,675
5/3/2023	Michael G. Grey	Director	Sell	14,608	$28.00	$409,024.00
11/14/2022	Niall O'donnell	Director	Sell	32,109	$19.60	$629,336.40	1,714,888
11/11/2022	Niall O'donnell	Director	Sell	174,121	$19.99	$3,480,678.79	1,746,997
6/6/2022	James E Flynn	Major Shareholder	Sell	38,478	$25.01	$962,334.78	1,540,190
11/26/2021	Ian Clements	CFO	Buy	750	$13.90	$10,425.00
11/24/2021	Christopher Peetz	CEO	Buy	7,000	$14.40	$100,800.00
11/24/2021	Ian Clements	CFO	Buy	700	$14.40	$10,080.00
10/1/2021	Christopher Peetz	CEO	Sell	3,672	$19.26	$70,722.72
10/1/2021	Ian Clements	CFO	Sell	1,574	$19.26	$30,315.24
10/1/2021	Pamela Vig	Insider	Sell	1,364	$19.26	$26,270.64
7/9/2021	James E Flynn	Major Shareholder	Sell	99,325	$15.81	$1,570,328.25
7/6/2021	James E Flynn	Major Shareholder	Sell	49,239	$16.20	$797,671.80
7/2/2021	James E Flynn	Major Shareholder	Sell	10,599	$17.01	$180,288.99

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Mirum Pharmaceuticals (NASDAQ:MIRM)

Institutional Buying and Selling by Quarter

Mirum Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Raymond James Financial Services Advisors Inc.	97,891	$2.46M	0.0%	+63.0%	0.208%
4/18/2024	Allspring Global Investments Holdings LLC	18,455	$0.46M	0.0%	-20.0%	0.039%
4/17/2024	Hennion & Walsh Asset Management Inc.	63,534	$1.60M	0.1%	+31.0%	0.135%
4/16/2024	Wealth Enhancement Advisory Services LLC	31,489	$0.79M	0.0%	-2.7%	0.067%
4/5/2024	Los Angeles Capital Management LLC	41,836	$1.05M	0.0%	+10.8%	0.089%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	211,949	$6.26M	0.0%	+111.9%	0.451%
2/26/2024	Virtu Financial LLC	6,881	$0.20M	0.0%	-18.5%	0.015%
2/26/2024	Perceptive Advisors LLC	534,942	$15.79M	0.4%	-20.4%	1.148%
2/20/2024	Eventide Asset Management LLC	2,663,649	$78.63M	1.3%	-32.7%	5.715%
2/15/2024	Octagon Capital Advisors LP	25,000	$0.74M	0.1%	N/A	0.054%
2/15/2024	Frazier Life Sciences Management L.P.	6,495,392	$191.74M	10.3%	+0.4%	13.934%
2/15/2024	Boone Capital Management LLC	490,139	$14.47M	3.4%	+25.7%	1.051%
2/14/2024	Cadian Capital Management LP	1,934,922	$57.12M	2.3%	+34.8%	4.151%
2/14/2024	Partners Group Holding AG	18,271	$0.54M	0.1%	N/A	0.039%
2/14/2024	StepStone Group LP	4,568	$0.14M	0.0%	N/A	0.010%
2/14/2024	CenterBook Partners LP	51,837	$1.53M	0.2%	+242.4%	0.111%
2/13/2024	Affinity Asset Advisors LLC	50,000	$1.48M	0.3%	+66.7%	0.107%
2/13/2024	Rafferty Asset Management LLC	130,346	$3.85M	0.0%	-5.0%	0.280%
2/13/2024	NEOS Investment Management LLC	7,442	$0.22M	0.0%	N/A	0.016%
2/13/2024	California State Teachers Retirement System	211,111	$6.23M	0.0%	+672.9%	0.453%
2/12/2024	TD Asset Management Inc	47,000	$1.39M	0.0%	N/A	0.101%
2/12/2024	Steward Partners Investment Advisory LLC	39,550	$1.17M	0.0%	+31.6%	0.085%
2/9/2024	Franklin Resources Inc.	913,068	$26.95M	0.0%	+22.6%	1.959%
2/9/2024	Quest Partners LLC	6,563	$0.19M	0.0%	N/A	0.014%
2/9/2024	Clearbridge Investments LLC	264,097	$7.80M	0.0%	+1,533.9%	0.567%
2/9/2024	Dynamic Technology Lab Private Ltd	16,282	$0.48M	0.1%	N/A	0.035%
2/8/2024	Great Lakes Advisors LLC	9,500	$0.28M	0.0%	N/A	0.020%
2/8/2024	Pathway Capital Management LP	190,286	$5.62M	6.3%	N/A	0.408%
2/8/2024	Janney Montgomery Scott LLC	24,100	$0.71M	0.0%	+27.3%	0.052%
2/8/2024	Nicholas Investment Partners LP	398,883	$11.78M	1.4%	-66.7%	0.856%
2/8/2024	First Turn Management LLC	836,302	$24.69M	3.5%	N/A	1.794%
2/7/2024	Jump Financial LLC	8,166	$0.24M	0.0%	-90.7%	0.018%
2/7/2024	Teacher Retirement System of Texas	137,216	$4.05M	0.0%	+1,858.5%	0.294%
2/6/2024	Charles Schwab Investment Management Inc.	266,681	$7.87M	0.0%	+18.8%	0.572%
2/6/2024	AJOVista LLC	1,364	$40K	0.1%	N/A	0.003%
2/6/2024	Los Angeles Capital Management LLC	37,767	$1.12M	0.0%	-11.0%	0.081%
2/6/2024	Swiss National Bank	59,300	$1.75M	0.0%	+9.0%	0.127%
2/5/2024	Victory Capital Management Inc.	20,120	$0.59M	0.0%	N/A	0.043%
2/5/2024	Russell Investments Group Ltd.	15,656	$0.46M	0.0%	-4.7%	0.034%
2/2/2024	Golden State Equity Partners	18,930	$0.56M	0.1%	+5.3%	0.041%
2/2/2024	Tokio Marine Asset Management Co. Ltd.	13,051	$0.39M	0.0%	N/A	0.028%
2/1/2024	New York State Common Retirement Fund	222,864	$6.58M	0.0%	+0.4%	0.478%
1/31/2024	Wetzel Investment Advisors Inc.	1,400	$41K	0.0%	N/A	0.003%
1/31/2024	Knights of Columbus Asset Advisors LLC	116,644	$3.44M	0.2%	+101.6%	0.250%
1/31/2024	Federated Hermes Inc.	5,000	$0.15M	0.0%	-75.7%	0.011%
1/30/2024	Genworth Financial Inc	13,051	$0.39M	0.1%	N/A	0.028%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	8,601	$0.25M	0.0%	+74.3%	0.018%
1/24/2024	Arizona State Retirement System	8,413	$0.25M	0.0%	+19.5%	0.018%
1/24/2024	China Universal Asset Management Co. Ltd.	5,394	$0.16M	0.0%	+447.1%	0.012%
1/22/2024	Secure Asset Management LLC	39,203	$1.16M	0.3%	-1.2%	0.084%
1/18/2024	Values First Advisors Inc.	16,740	$0.49M	0.3%	-55.9%	0.036%
1/16/2024	Raymond James Financial Services Advisors Inc.	60,047	$1.77M	0.0%	+20.4%	0.129%
1/16/2024	Raymond James & Associates	135,682	$4.01M	0.0%	+27.8%	0.291%
1/16/2024	Legato Capital Management LLC	39,807	$1.18M	0.2%	+9.6%	0.085%
1/12/2024	SG Americas Securities LLC	12,405	$0.37M	0.0%	-51.8%	0.027%
12/18/2023	Vanguard Group Inc.	1,693,343	$53.51M	0.0%	+6.2%	3.633%
11/22/2023	Polar Capital Holdings Plc	1,175,000	$37.13M	0.3%	+27.0%	2.521%
11/15/2023	Adage Capital Partners GP L.L.C.	665,000	$21.01M	0.0%	N/A	1.427%
11/15/2023	Ardsley Advisory Partners LP	100,000	$3.16M	0.7%	N/A	0.215%
11/14/2023	Eventide Asset Management LLC	3,958,579	$125.09M	2.3%	+14.4%	8.493%
11/14/2023	Schonfeld Strategic Advisors LLC	21,799	$0.69M	0.0%	-42.3%	0.047%
11/14/2023	Cadian Capital Management LP	1,434,922	$45.34M	1.8%	+13.4%	3.079%
11/14/2023	Boone Capital Management LLC	389,791	$12.32M	3.9%	N/A	0.836%
11/14/2023	Avidity Partners Management LP	1,142,850	$36.11M	1.5%	N/A	2.452%
11/14/2023	Profund Advisors LLC	23,056	$0.73M	0.0%	+9.2%	0.049%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	114,109	$3.61M	0.0%	+202.4%	0.245%
11/13/2023	Federated Hermes Inc.	20,544	$0.65M	0.0%	+71.2%	0.044%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	100,000	$3.16M	0.0%	N/A	0.215%
11/13/2023	Clearbridge Investments LLC	16,164	$0.51M	0.0%	-21.4%	0.035%
11/13/2023	CenterBook Partners LP	15,138	$0.48M	0.1%	-46.2%	0.032%
11/13/2023	Silverarc Capital Management LLC	110,114	$3.48M	1.1%	+3.5%	0.236%
11/13/2023	Rafferty Asset Management LLC	137,205	$4.34M	0.0%	+18.4%	0.294%
11/13/2023	E Fund Management Co. Ltd.	7,050	$0.22M	0.0%	N/A	0.015%
11/9/2023	William Blair Investment Management LLC	533,693	$16.87M	0.1%	+58.2%	1.145%
11/9/2023	Deutsche Bank AG	14,364	$0.45M	0.0%	-87.1%	0.031%
11/9/2023	Citigroup Inc.	58,723	$1.86M	0.0%	+43.9%	0.126%
11/8/2023	Campbell & CO Investment Adviser LLC	28,556	$0.90M	0.1%	+90.7%	0.075%
11/8/2023	State Board of Administration of Florida Retirement System	7,947	$0.25M	0.0%	N/A	0.021%
11/8/2023	Charles Schwab Investment Management Inc.	224,571	$7.10M	0.0%	+210.7%	0.586%
11/8/2023	Janney Montgomery Scott LLC	18,925	$0.60M	0.0%	+5.3%	0.049%
11/8/2023	Swiss National Bank	54,400	$1.72M	0.0%	+1.3%	0.142%
11/8/2023	Values First Advisors Inc.	37,919	$1.20M	0.8%	N/A	0.099%
11/8/2023	Amalgamated Bank	3,369	$0.11M	0.0%	-10.3%	0.009%
11/7/2023	Virtus ETF Advisers LLC	10,739	$0.34M	0.2%	-11.5%	0.028%
11/7/2023	Quantbot Technologies LP	12,069	$0.38M	0.0%	N/A	0.032%
11/7/2023	New York State Common Retirement Fund	221,946	$7.01M	0.0%	+6.1%	0.579%
11/7/2023	Barclays PLC	299,120	$9.45M	0.0%	+4.2%	0.781%
11/7/2023	Jump Financial LLC	87,384	$2.76M	0.1%	+607.0%	0.228%
11/7/2023	Arizona State Retirement System	7,038	$0.22M	0.0%	N/A	0.018%
11/6/2023	Los Angeles Capital Management LLC	42,444	$1.34M	0.0%	+1.2%	0.111%
11/2/2023	Rice Hall James & Associates LLC	53,379	$1.69M	0.1%	-2.0%	0.139%
11/1/2023	Knights of Columbus Asset Advisors LLC	57,871	$1.83M	0.2%	+1.4%	0.151%
10/31/2023	Teacher Retirement System of Texas	7,006	$0.22M	0.0%	N/A	0.018%
10/31/2023	China Universal Asset Management Co. Ltd.	986	$31K	0.0%	+98.0%	0.003%
10/27/2023	Hennion & Walsh Asset Management Inc.	26,493	$0.84M	0.0%	+89.5%	0.069%
10/27/2023	Allspring Global Investments Holdings LLC	23,033	$0.73M	0.0%	-45.3%	0.060%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	17,106	$0.54M	0.0%	+21.9%	0.045%
10/24/2023	Bank of New York Mellon Corp	118,051	$3.73M	0.0%	+5.2%	0.308%
10/24/2023	Raymond James Financial Services Advisors Inc.	49,891	$1.58M	0.0%	+31.2%	0.130%
10/24/2023	Raymond James & Associates	106,207	$3.36M	0.0%	+57.1%	0.277%

Data available starting January 2016

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.

Today's Range

Now: $24.17

$23.75

$24.51

50 Day Range

MA: $26.77

$23.57

$29.61

52 Week Range

Now: $24.17

$23.29

$35.56

Volume

254,735 shs

Average Volume

419,077 shs

Market Capitalization

$1.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

Who are the company insiders with the largest holdings of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top insider investors include:
Niall O'donnell (Director)
James E Flynn (Major Shareholder)
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Peter Radovich (COO)
Eric Bjerkholt (CFO)
Jolanda Howe (SVP)
Michael G Grey (Director)
Learn More about top insider investors at Mirum Pharmaceuticals.
Who are the major institutional investors of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top institutional investors include:
Raymond James Financial Services Advisors Inc. — 0.21%
Hennion & Walsh Asset Management Inc. — 0.14%
Los Angeles Capital Management LLC — 0.09%
Wealth Enhancement Advisory Services LLC — 0.07%
Allspring Global Investments Holdings LLC — 0.04%
Learn More about top institutional investors of Mirum Pharmaceuticals stock.
Which institutional investors are selling Mirum Pharmaceuticals stock?: During the last quarter, MIRM stock was sold by these institutional investors:
Allspring Global Investments Holdings LLC
Wealth Enhancement Advisory Services LLC
Within the last year, company insiders that have sold Mirum Pharmaceuticals company stock include:
Niall O'donnell (Director)
James E Flynn (Major Shareholder)
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Learn More investors selling Mirum Pharmaceuticals stock.
Which institutional investors are buying Mirum Pharmaceuticals stock?: In the last quarter, MIRM stock was bought by institutional investors including:
Raymond James Financial Services Advisors Inc.
Hennion & Walsh Asset Management Inc.
Los Angeles Capital Management LLC
Within the last year, these company insiders have bought Mirum Pharmaceuticals stock:
Niall O'donnell (Director)
James E Flynn (Major Shareholder)
Learn More investors buying Mirum Pharmaceuticals stock.